1. Efficacy and safety of intravenous immunoglobulin with rituximab versus rituximab alone in childhood-onset steroid-dependent and frequently relapsing nephrotic syndrome: protocol for a multicentre randomised controlled trial. Issue 9 (23rd September 2020) Authors: Hogan, Julien; Perez, Aubriana; Sellier-Leclerc, Anne-Laure; Vrillon, Isabelle; Broux, Francoise; Nobili, Francois; Harambat, Jerome; Bessenay, Lucie; Audard, V; Faudeux, Camille; Morin, Denis; Pietrement, Christine; Tellier, Stephanie; Djeddi, Djamal; Eckart, Philippe; Lahoche, Annie; Roussey-Ke... Journal: BMJ open Issue: Volume 10:Issue 9(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OP0147 KAWAKINRA: A PHASE IIA MULTICENTER TRIAL TO ASSESS THE EFFICACY, AND SAFETY OF ANAKINRA IN PATIENTS WITH INTRAVENOUS IMMUNOGLOBULIN-RESISTANT KAWASAKI DISEASE. (June 2019) Authors: Koné-Paut, Isabelle; Tellier, Stephanie; Lambert, Virginie; Guitton, Corinne; Belot, Alexandre; Dusser, Perrine; Rossi-Semerano, Linda; Marie, Isabelle; Allain, Gregory; Agostini, Helene; Piedvache, Celine Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 2 Page Start: 149 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗